733 related articles for article (PubMed ID: 29154109)
1. Development and validation of a sensitive and rapid UHPLC-MS/MS method for the simultaneous quantification of the common active and inactive metabolites of vicagrel and clopidogrel in human plasma.
Liu C; Lu Y; Sun H; Yang J; Liu Y; Lai X; Gong Y; Liu X; Li Y; Zhang Y; Chen X; Zhong D
J Pharm Biomed Anal; 2018 Feb; 149():394-402. PubMed ID: 29154109
[TBL] [Abstract][Full Text] [Related]
2. HPLC-MS/MS method for the simultaneous determination of clopidogrel, its carboxylic acid metabolite and derivatized isomers of thiol metabolite in clinical samples.
Karaźniewicz-Łada M; Danielak D; Teżyk A; Zaba C; Tuffal G; Główka F
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Dec; 911():105-12. PubMed ID: 23217313
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y
Liu C; Zhang Y; Chen W; Lu Y; Li W; Liu Y; Lai X; Gong Y; Liu X; Li Y; Chen X; Li X; Sun H; Yang J; Zhong D
Eur J Pharm Sci; 2019 Jan; 127():151-160. PubMed ID: 30326264
[TBL] [Abstract][Full Text] [Related]
4. Development and validation of a UPLC-MS/MS method for simultaneous determination of vicagrel and its major metabolites in rat or human plasma: An optimized novel strategy for the stabilization of vicagrel.
Tai T; Zhou H; Zhu T; Jia YM; Ji JZ; Li YF; Mi QY; Xie HG
J Pharm Biomed Anal; 2020 Feb; 179():112955. PubMed ID: 31866139
[TBL] [Abstract][Full Text] [Related]
5. Quantitative determination of clopidogrel active metabolite in human plasma by LC-MS/MS.
Takahashi M; Pang H; Kawabata K; Farid NA; Kurihara A
J Pharm Biomed Anal; 2008 Dec; 48(4):1219-24. PubMed ID: 18829199
[TBL] [Abstract][Full Text] [Related]
6. A validated HPLC-MS/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; Savant I; Yuan M; Scott L; Mylott W; Mariannino T; Kadiyala P; Roongta V; Arnold ME
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 926():36-41. PubMed ID: 23542721
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of vicagrel, a promising analog of clopidogrel, in rats and beagle dogs.
Qiu Z; Li N; Wang X; Tian F; Liu Q; Song L; Fan Z; Lu Y; Chen X
J Pharm Sci; 2013 Feb; 102(2):741-9. PubMed ID: 23192851
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of high-throughput liquid chromatography-tandem mass spectrometric method for simultaneous quantification of clopidogrel and its metabolite in human plasma.
Reddy S R; Rao Divi K; Chandiran IS; Jayaveera KN; Naidu YK; Reddy MP
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Feb; 878(3-4):502-8. PubMed ID: 20060791
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous determination of bentysrepinine (Y101) and its metabolites M8 and M9 in human plasma by UPLC-MS/MS and its application to a pharmacokinetic study.
Liu X; Huang C; Xue L; Xu Q; Xia W; Li X; Miao L
J Pharm Biomed Anal; 2018 Feb; 150():287-293. PubMed ID: 29258048
[TBL] [Abstract][Full Text] [Related]
10. A sensitive and rapid ultra HPLC-MS/MS method for the simultaneous detection of clopidogrel and its derivatized active thiol metabolite in human plasma.
Peer CJ; Spencer SD; VanDenBerg DA; Pacanowski MA; Horenstein RB; Figg WD
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 880(1):132-9. PubMed ID: 22169056
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics, mass balance, and metabolism of [
Zheng YD; Zhang H; Zhan Y; Bian YC; Ma S; Gan HX; Lai XJ; Liu YQ; Gong YC; Liu XF; Sun HB; Li YG; Zhong DF; Miao LY; Diao XX
Acta Pharmacol Sin; 2021 Sep; 42(9):1535-1546. PubMed ID: 33244163
[TBL] [Abstract][Full Text] [Related]
12. Significant Improvement of Metabolic Characteristics and Bioactivities of Clopidogrel and Analogs by Selective Deuteration.
Xu X; Zhao X; Yang Z; Wang H; Meng X; Su C; Liu M; Fawcett JP; Yang Y; Gu J
Molecules; 2016 May; 21(6):. PubMed ID: 27248988
[TBL] [Abstract][Full Text] [Related]
13. The validation of a bioanalytical method for the determination of clopidogrel in human plasma.
Robinson A; Hillis J; Neal C; Leary AC
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Apr; 848(2):344-54. PubMed ID: 17141580
[TBL] [Abstract][Full Text] [Related]
14. Overcoming the stability, solubility and extraction challenges in reversed-phase UHPLC-MS/MS bioanalysis of a phosphate drug and its prodrug in blood lysate.
Yuan L; Basdeo S; Ji QC
J Pharm Biomed Anal; 2018 Aug; 157():36-43. PubMed ID: 29758468
[TBL] [Abstract][Full Text] [Related]
15. A validated enantioselective LC-MS/MS assay for the simultaneous determination of carvedilol and its pharmacologically active 4'-hydroxyphenyl metabolite in human plasma: application to a clinical pharmacokinetic study.
Furlong MT; He B; Mylott W; Zhao S; Mariannino T; Shen J; Stouffer B
J Pharm Biomed Anal; 2012 Nov; 70():574-9. PubMed ID: 22709607
[TBL] [Abstract][Full Text] [Related]
16. Determination of clopidogrel metabolite (SR26334) in human plasma by LC-MS.
Ksycinska H; Rudzki P; Bukowska-Kiliszek M
J Pharm Biomed Anal; 2006 May; 41(2):533-9. PubMed ID: 16406450
[TBL] [Abstract][Full Text] [Related]
17. An improved method for specific and quantitative determination of the clopidogrel active metabolite isomers in human plasma.
Tuffal G; Roy S; Lavisse M; Brasseur D; Schofield J; Delesque Touchard N; Savi P; Bremond N; Rouchon MC; Hurbin F; Sultan E
Thromb Haemost; 2011 Apr; 105(4):696-705. PubMed ID: 21301779
[TBL] [Abstract][Full Text] [Related]
18. Rapid determination of canagliflozin in rat plasma by UHPLC-MS/MS using negative ionization mode to avoid adduct-ions formation.
Iqbal M; Ezzeldin E; Al-Rashood KA; Asiri YA; Rezk NL
Talanta; 2015 Jan; 132():29-36. PubMed ID: 25476275
[TBL] [Abstract][Full Text] [Related]
19. Development, validation and application of a novel HPLC-MS/MS method for the quantification of atorvastatin, bisoprolol and clopidogrel in a large cardiovascular patient cohort.
Turner RM; Fontana V; Bayliss M; Whalley S; Santoyo Castelazo A; Pirmohamed M
J Pharm Biomed Anal; 2018 Sep; 159():272-281. PubMed ID: 30005242
[TBL] [Abstract][Full Text] [Related]
20. Development of a sensitive UPLC-ESI-MS/MS method for quantification of sofosbuvir and its metabolite, GS-331007, in human plasma: Application to a bioequivalence study.
Rezk MR; Basalious EB; Karim IA
J Pharm Biomed Anal; 2015 Oct; 114():97-104. PubMed ID: 26037157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
